PADI4 and colorectal cancer: To observe the consequences of PADI4-mediated DNMT3A upregulation specifically, we used the colorectal cancer cell line HCT-116, where both the DNMT1 and DNMT3B DNMTs have been genetically disrupted (DKO cells) and where DNMT activity is minimal (38).